These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9416807)

  • 21. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.
    Parry A; Clare S; Jenkinson M; Smith S; Palace J; Matthews PM
    J Neurol; 2002 Sep; 249(9):1279-86. PubMed ID: 12242554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Total brain T2-hyperintense lesion-volume and the axonal damage in the normal-appearing white matter of brainstem in early lapsing-remitting multiple sclerosis].
    Pascual-Lozano AM; Martínez-Bisbal MC; Boscá-Blasco I; Valero-Merino C; Coret-Ferrer F; Martí-Bonmatí L; Martínez-Granados B; Celda B; Casanova-Estruch B
    Rev Neurol; 2007 Oct 16-31; 45(8):468-73. PubMed ID: 17948212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis.
    Yeh EA; Weinstock-Guttman B; Ramanathan M; Ramasamy DP; Willis L; Cox JL; Zivadinov R
    Brain; 2009 Dec; 132(Pt 12):3392-400. PubMed ID: 19892770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
    Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
    Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).
    Schneider R; Bellenberg B; Hoepner R; Kolb EM; Ellrichmann G; Haghikia A; Gold R; Lukas C
    PLoS One; 2017; 12(4):e0176415. PubMed ID: 28445498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
    De Stefano N; Battaglini M; Stromillo ML; Zipoli V; Bartolozzi ML; Guidi L; Siracusa G; Portaccio E; Giorgio A; Sorbi S; Federico A; Amato MP
    Brain; 2006 Aug; 129(Pt 8):2008-16. PubMed ID: 16815879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of multiple sclerosis patients with magnetic resonance spectroscopic imaging.
    Peters AR; Geelen JA; den Boer JA; Prevo RL; Minderhoud JM; 's Gravenmade EJ
    Mult Scler; 1995 Apr; 1(1):25-31. PubMed ID: 9345466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI.
    Dal-Bianco A; Grabner G; Kronnerwetter C; Weber M; Kornek B; Kasprian G; Berger T; Leutmezer F; Rommer PS; Trattnig S; Lassmann H; Hametner S
    Brain; 2021 Apr; 144(3):833-847. PubMed ID: 33484118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T.
    Pan JW; Hetherington HP; Vaughan JT; Mitchell G; Pohost GM; Whitaker JN
    Magn Reson Med; 1996 Jul; 36(1):72-7. PubMed ID: 8795023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome.
    Giannetti P; Politis M; Su P; Turkheimer FE; Malik O; Keihaninejad S; Wu K; Waldman A; Reynolds R; Nicholas R; Piccini P
    Brain; 2015 Jan; 138(Pt 1):110-9. PubMed ID: 25416179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.
    Bjartmar C; Kidd G; Mörk S; Rudick R; Trapp BD
    Ann Neurol; 2000 Dec; 48(6):893-901. PubMed ID: 11117546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.
    Oh J; Pelletier D; Nelson SJ
    Arch Neurol; 2004 Jul; 61(7):1081-6. PubMed ID: 15262739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
    He J; Inglese M; Li BS; Babb JS; Grossman RI; Gonen O
    Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.
    Duan Y; Liu Z; Liu Y; Huang J; Ren Z; Sun Z; Chen H; Dong H; Ye J; Li K
    Acta Radiol; 2017 Sep; 58(9):1132-1137. PubMed ID: 28173728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance.
    Horsfield MA; Lai M; Webb SL; Barker GJ; Tofts PS; Turner R; Rudge P; Miller DH
    Magn Reson Med; 1996 Sep; 36(3):393-400. PubMed ID: 8875409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cortical demyelination and diffuse white matter injury in multiple sclerosis.
    Kutzelnigg A; Lucchinetti CF; Stadelmann C; Brück W; Rauschka H; Bergmann M; Schmidbauer M; Parisi JE; Lassmann H
    Brain; 2005 Nov; 128(Pt 11):2705-12. PubMed ID: 16230320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
    Barkhof F; van Walderveen M
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1675-86. PubMed ID: 10603619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
    Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
    Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. White matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders.
    Longoni G; Brown RA; MomayyezSiahkal P; Elliott C; Narayanan S; Bar-Or A; Marrie RA; Yeh EA; Filippi M; Banwell B; Arnold DL;
    Brain; 2017 May; 140(5):1300-1315. PubMed ID: 28334875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis.
    Evangelou N; Esiri MM; Smith S; Palace J; Matthews PM
    Ann Neurol; 2000 Mar; 47(3):391-5. PubMed ID: 10716264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.